Search

Photocathodes are key elements in high-brightness electron sources and ubiquitous in the operation of large-scale accelerators, although their operation is often limited by their quantum efficiency and lifetime. Here, we propose to overcome these limitations by utilizing direct-laser nanostructuring techniques on copper substrates, improving their efficiency and robustness for next-generation electron photoinjectors. When the surface of a metal is nanoengineered with patterns and particles much smaller than the optical wavelength, it can lead to the excitation of localized surface plasmons that produce hot electrons, ultimately contributing to the overall charge produced. In order to quantify the performance of laser-produced plasmonic photocathodes, we measured their quantum efficiency in a typical electron gun setup. Our experimental results suggest that plasmon-induced hot electrons lead to a significant increase in quantum efficiency, showing an overall charge enhancement factor of at least 4.5 and up to 25. A further increase in their efficiency was observed when combined with semiconductor thin-films deposited over the laser processed surfaces, pointing at potential pathways for further optimization. We demonstrate that simple laser-produced plasmonic photocathodes outperform standard metallic photocathodes, and can be directly produced in-situ at the electron gun level in vacuum environments and without any disruptive intervention. This approach could lead to unprecedented efficient and continuous operation of electron sources, and is useful in many applications across scientific disciplines requiring high average and peak current electron beams.

Photocathodes are key elements in high-brightness electron sources and ubiquitous in the operation of large-scale accelerators, although their operation is often limited by their quantum efficiency and lifetime. Here, we propose to overcome these limitations by utilizing direct-laser nanostructuring techniques on copper substrates, improving their efficiency and robustness for next-generation electron photoinjectors. When the surface of a metal is nanoengineered with patterns and particles much smaller than the optical wavelength, it can lead to the excitation of localized surface plasmons that produce hot electrons, ultimately contributing to the overall charge produced. In order to quantify the performance of laser-produced plasmonic photocathodes, we measured their quantum efficiency in a typical electron gun setup. Our experimental results suggest that plasmon-induced hot electrons lead to a significant increase in quantum efficiency, showing an overall charge enhancement factor of at least 4.5 and up to 25. A further increase in their efficiency was observed when combined with semiconductor thin-films deposited over the laser processed surfaces, pointing at potential pathways for further optimization. We demonstrate that simple laser-produced plasmonic photocathodes outperform standard metallic photocathodes, and can be directly produced in-situ at the electron gun level in vacuum environments and without any disruptive intervention. This approach could lead to unprecedented efficient and continuous operation of electron sources, and is useful in many applications across scientific disciplines requiring high average and peak current electron beams. [ABSTRACT FROM AUTHOR]

Tunable single‐frequency lasers are the most prominent tool for high‐resolution spectroscopy, allowing for the study and exploitation of the electronic structure of atoms. A significant milestone relies on the demonstration of integrated laser technology for performing such a task. The device presented here is composed of a compact Fabry–Perot monolithic resonator capable of producing tunable and Fourier‐limited nanosecond pulses with a MHz‐class frequency stability without active cavity stabilization elements. It also has the remarkable capability of exploiting the Raman effect to funnel efficiently the broad spectrum of an input laser to a spectrally‐bright Stokes pulse at hard‐to‐access wavelength ranges. The targeted atom for the demonstrations is 152Sm, released as an atomic vapor in a hot cavity environment. Here, the Stokes field is tuned to a wavelength of 433.9 nm, while a crossed‐beams spectroscopy setup is used to minimize the Doppler broadened spectral features of the atoms. With this work, the suitability of integrated diamond Raman lasers as a high‐resolution in‐source spectroscopy tool is demonstrated, enabling many applications in atomic and nuclear physics. The integrated form‐factor and inherent simplicity makes such a laser an interesting prospect for quantum‐technology based sensing systems and related applications. [ABSTRACT FROM AUTHOR]

Author(s): Hans O. U. Fynbo (corresponding author) [1]; Christian Aa. Diget [1]; Uffe C. Bergmann [2]; Maria J. G. Borge [3]; Joakim Cederkäll [2]; Peter Dendooven [4]; Luis M. Fraile [...]

In the centres of stars where the temperature is high enough, threea-particles (helium nuclei) are able to combine to form12C because of a resonant reaction leading to a nuclear excited state. (Stars with masses greater than~0.5 times that of the Sun will at some point in their lives have a central temperature high enough for this reaction to proceed.) Although the reaction rate is of critical significance for determining elemental abundances in the Universe, and for determining the size of the iron core of a star just before it goes supernova, it has hitherto been insufficiently determined. Here we report a measurement of the inverse process, where a12C nucleus decays to threea-particles. We find a dominant resonance at an energy of~11?MeV, but do not confirm the presence of a resonance at 9.1?MeV (ref. 3). We show that interference between two resonances has important effects on our measured spectrum. Using these data, we calculate the triple-arate for temperatures from 107?K to 1010?K and find significant deviations from the standard rates. Our rate below~5×107?K is higher than the previous standard, implying that the critical amounts of carbon that catalysed hydrogen burning in the first stars are produced twice as fast as previously believed. At temperatures above 109?K, our rate is much less, which modifies predicted nucleosynthesis in supernovae. [ABSTRACT FROM AUTHOR]

The CERN-MEDICIS (MEDical Isotopes Collected from ISolde) facility has delivered its first radioactive ion beam at CERN (Switzerland) in December 2017 to support the research and development in nuclear medicine using non-conventional radionuclides. Since then, fourteen institutes, including CERN, have joined the collaboration to drive the scientific program of this unique installation and evaluate the needs of the community to improve the research in imaging, diagnostics, radiation therapy and personalized medicine. The facility has been built as an extension of the ISOLDE (Isotope Separator On Line DEvice) facility at CERN. Handling of open radioisotope sources is made possible thanks to its Radiological Controlled Area and laboratory. Targets are being irradiated by the 1.4 GeV proton beam delivered by the CERN Proton Synchrotron Booster (PSB) on a station placed between the High Resolution Separator (HRS) ISOLDE target station and its beam dump. Irradiated target materials are also received from external institutes to undergo mass separation at CERN-MEDICIS. All targets are handled via a remote handling system and exploited on a dedicated isotope separator beamline. To allow for the release and collection of a specific radionuclide of medical interest, each target is heated to temperatures of up to 2,300°C. The created ions are extracted and accelerated to an energy up to 60 kV, and the beam steered through an off-line sector field magnet mass separator. This is followed by the extraction of the radionuclide of interest through mass separation and its subsequent implantation into a collection foil. In addition, the MELISSA (MEDICIS Laser Ion Source Setup At CERN) laser laboratory, in service since April 2019, helps to increase the separation efficiency and the selectivity. After collection, the implanted radionuclides are dispatched to the biomedical research centers, participating in the CERN-MEDICIS collaboration, for Research & Development in imaging or treatment. Since its commissioning, the CERN-MEDICIS facility has provided its partner institutes with non-conventional medical radionuclides such as Tb-149, Tb-152, Tb-155, Sm-153, Tm-165, Tm-167, Er-169, Yb-175, and Ac-225 with a high specific activity. This article provides a review of the achievements and milestones of CERN-MEDICIS since it has produced its first radioactive isotope in December 2017, with a special focus on its most recent operation in 2020., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Duchemin, Ramos, Stora, Ahmed, Aubert, Audouin, Barbero, Barozier, Bernardes, Bertreix, Boscher, Bruchertseifer, Catherall, Chevallay, Christodoulou, Chrysalidis, Cocolios, Comte, Crepieux, Deschamps, Dockx, Dorsival, Fedosseev, Fernier, Formento-Cavaier, El Idrissi, Ivanov, Gadelshin, Gilardoni, Grenard, Haddad, Heinke, Juif, Khalid, Khan, Köster, Lambert, Lilli, Lunghi, Marsh, Palenzuela, Martins, Marzari, Menaa, Michel, Munos, Pozzi, Riccardi, Riegert, Riggaz, Rinchet, Rothe, Russell, Saury, Schneider, Stegemann, Talip, Theis, Thiboud, van der Meulen, van Stenis, Vincke, Vollaire, Vuong, Webster, Wendt, Wilkins and the CERN-MEDICIS collaboration.)